![](https://investorshub.advfn.com/uicon/604629.png?cb=1503346726)
Thursday, April 27, 2017 10:38:56 AM
see https://www.tradingview.com/x/bNcIJKll/
(post copied & merged from other board, johnny007 @ stockhouse.com, thank you)
My chart is shown as linked above, RT market data via tradeview and the only cross down, aka dead cross, I can see is on 4/24 50ma x 20ma, not the golden 200ma Sir!
Sure, that was bad, hence we are back at the channel bottom.
I propose nothing to anybody here, just inform you that I see a reversal play going on right now,
since this is the usual channel trading. If you use charts, well - then you should know.
Fundamentally the company's balance sheet is of course quite weak and this is only played due to anticipation that their liquid biopsy testing receives more insurance contracts and/or a buyout.
But hey, 4Q16 was even profitable .. a little bit, that was a great sign of execution, besides the liquidity issues they had. I do expect a great turnaround in 2017.
On another positive note, .30 held today and it does prove support. Especially that over 100k trade, as you like watching the tape.
Yes, it is too early to read the indicators and I play this merely on it's strong support range .29 - .31 for the channel surfing and maybe even good news on the way up.
Further, I have marked 3 occasions in the chart w/ same daily candlestick and the last one had a short 50ma x 20ma 'dead' cross as well, those don't last long w/ this stock's trade. Price and channel bound.
With this .30'ish support we should at least expect a 200ma snap-back, happens quite often. I trade this not only for the bounce, but in the hope that we receive that insurance deal update as anticipated on the way up .. we will see.
Recent GEN News
- Gen Launches Scam Artists to Highlight Emotional Toll of Cybercrime Through Creative Artwork • PR Newswire (US) • 07/10/2024 01:00:00 PM
- Gen to Announce Fiscal 2025 First Quarter Results on August 1, 2024 • PR Newswire (US) • 07/09/2024 08:02:00 PM
- Epcoritamab (TEPKINLY®) Receives Positive CHMP Opinion for the Treatment of Adults with Relapsed/ Refractory Follicular Lymphoma • GlobeNewswire Inc. • 06/28/2024 06:00:00 AM
- Segic s'associe à Norton Benefit Solutions pour améliorer l'offre d'avantages sociaux de Segic grâce à un nouveau programme de sécurité numérique. • PR Newswire (Canada) • 06/26/2024 02:00:00 PM
- Segic Partners with Norton Benefit Solutions to Enhance Segic's Benefits Marketplace with a New Digital Security Program. • PR Newswire (Canada) • 06/26/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 01:04:56 PM
- Gen Releases its Fiscal 2024 Social Impact Report • PR Newswire (US) • 05/28/2024 03:00:00 PM
- Genmab Completes Acquisition of ProfoundBio • GlobeNewswire Inc. • 05/21/2024 03:06:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 01:45:50 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM